Source:http://linkedlifedata.com/resource/pubmed/id/17346664
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003018,
umls-concept:C0016030,
umls-concept:C0017262,
umls-concept:C0018787,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0041455,
umls-concept:C0185117,
umls-concept:C0287592,
umls-concept:C0439097,
umls-concept:C1547348,
umls-concept:C1705241,
umls-concept:C1879547,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-4-2
|
pubmed:abstractText |
Peroxisome proliferator-activated receptors (PPARalpha, beta/delta and gamma) are nuclear receptors and PPARgamma activation was previously reported to inhibit collagen expression in the heart, but whether PPARbeta/delta also regulates collagen expression in the heart remains unclear. In this study, we investigated the effect of PPARbeta/delta activation on angiotensin II (Ang II)-induced collagen type I expression in adult rat cardiac fibroblasts. The results showed that PPARbeta/delta was expressed at the moderate level in cardiac fibroblasts. GW501516, a selective PPARbeta/delta agonist, depressed Ang II-stimulated collagen type I expression and collagen synthesis in cardiac fibroblasts in a concentration-dependent manner. Furthermore, these inhibitory effects of GW501516 were completely reversed by the knockdown of PPARbeta/delta via RNA interference. In summary, we find that PPARbeta/delta is present in cardiac fibroblasts and PPARbeta/delta activation inhibits Ang II-induced collagen type I expression at least in part via decreasing collagen synthesis. PPARbeta/delta may be a promising therapeutic target for myocardial fibrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I,
http://linkedlifedata.com/resource/pubmed/chemical/GW 501516,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR delta,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR-beta,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-9861
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
460
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
25-32
|
pubmed:meshHeading |
pubmed-meshheading:17346664-Angiotensin II,
pubmed-meshheading:17346664-Animals,
pubmed-meshheading:17346664-Collagen Type I,
pubmed-meshheading:17346664-Dose-Response Relationship, Drug,
pubmed-meshheading:17346664-Fibroblasts,
pubmed-meshheading:17346664-Male,
pubmed-meshheading:17346664-Myocardium,
pubmed-meshheading:17346664-PPAR delta,
pubmed-meshheading:17346664-PPAR-beta,
pubmed-meshheading:17346664-RNA Interference,
pubmed-meshheading:17346664-Rats,
pubmed-meshheading:17346664-Rats, Sprague-Dawley,
pubmed-meshheading:17346664-Thiazoles
|
pubmed:year |
2007
|
pubmed:articleTitle |
PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
|
pubmed:affiliation |
Laboratory of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|